Yuvanci

Yuvanci combines Tadalafil and Macitentan for oral use, supporting pulmonary arterial hypertension management. This dual-therapy option targets blood vessel relaxation and pressure reduction. Suitable for adults under medical supervision. Short-term relief and long-term support in one formulation.

Yuvanci is used to treat pulmonary arterial hypertension by improving blood flow and reducing pressure in the lungs. Tadalafil supports blood vessel relaxation while Macitentan reduces vascular resistance. It helps enhance exercise capacity and delay disease progression in adults. Commonly prescribed for those needing combined therapy.

Users may notice improved breathing and reduced fatigue during daily activities. The combination works gradually, with effects becoming more apparent over weeks of consistent use. Some individuals report better oxygen levels and reduced symptoms like dizziness or chest discomfort.

Store Yuvanci at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid splitting or crushing tablets unless advised by a healthcare provider. Report any unusual swelling, especially in the face or limbs, to a medical professional promptly.

Yuvanci may interact with other vasodilators, blood pressure medications, or CYP3A4 inhibitors like ketoconazole. Grapefruit juice could increase side effects due to enzyme interference. Alcohol may enhance hypotensive effects, leading to dizziness. Always disclose all medications to your doctor before starting Yuvanci.